July 11 – Perrigo Firm mentioned on Monday its unit has submitted an software to the U.S. Meals and Drug Administration (FDA) for approval of an over-the-counter (OTC) contraception tablet.
The applying from the Paris-based HRA Pharma comes on the again of the U.S. Supreme Courtroom’s choice in June to overturn the 1973 Roe v. Wade case that legalized abortion nationwide.
If accepted, the contraceptive, which is presently a prescription drug beneath the model Opill, can be the primary day by day contraception tablet accessible with out a prescription within the U.S., the corporate mentioned.
The non-estrogen tablet has been used with prescription because it was FDA-approved in 1973. Perrigo mentioned scientific proof has proven progestin-only drugs like Opill are efficient at stopping being pregnant and secure for most girls to make use of.
The conservative-leaning U.S. Supreme Courtroom’s choice final month curbing the appropriate to an abortion has shifted the main target to options.
Abortion rights activists have stepped up calls to make mifepristone, which together with a second drug referred to as misoprostol induces an abortion as much as 10 weeks right into a being pregnant, accessible OTC.
